Adaptive Pharmacogenomics, LLC
Clinical development for personalized medicine
Consulting
Biomarkers in your clinical development programs--will the benefits outweigh the costs? Our longstanding relationship with the FDA and industry puts us in a unique position to address this question. Our consulting practice uses unique modeling and visualization techniques developed during six years of working with the FDA on biomarkers in clinical development.
The Platform
Put your modeling and simulation tools into the state-of-the-art software platform that we developed with the FDA. Scientifically capable, computationally able, web-based, and scalable, the APG software platform will support your modeling and simulation needs today, into the future, locally and globally.
Webinars
APG produces webinars that examine modern clinical trials design and improved R&D productivity from an analytical perspective. Our customers tells us that APG webinars foster intelligent discussions in their companies that span disciplines and encourage innovative thinking.
Partners and Customers
|
|
Register and use the FDA-APG software today! |
|
|
Before registering, we suggest that you click and view these two webinars! The FDA-Adaptive Pharmacogenomics webinar series on “FDA-Adaptive Pharmacogenomics Software Tool for Clinical Development Strategy Selection with Biomarkers” |
|
|
1. History, Motivation, and Use of the FDA-APG Software Tool Presented by Federico Goodsaid, Ph.D., Associate Director for Operations in Genomics and Biomarker Qualification Coordinator at the Office of Clinical Pharmacology/Office of Translational Sciences/CDER/ FDA and Michael Palmer, President, Adaptive Pharmacogenomics, LLC |
2. Methodology for using the FDA-APG software tool for assessing clinical program complexity and cost Presented by Michael Palmer, President, Adaptive Pharmacogenomics, LLC |
|
|
 Click for the mini-Guide documentation |
Register and use the FDA-APG software today. |
|
|
